Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2E-imidazolidinimine
- Correlated keywords
- 105827-78-9 936094-08-5 937701-26-3 1223531-53-0 1258963-04-0 1395144-24-7 AE-F-106464-00GR01B0 AEF AGST-03001 10646400GR01B0 AEF106464 AGST03001 Admire-2F Pro Advantage Flea Adulticide Advise Alias BAY-NTN-33893 NTN33893 Baimieshi Bayer Advanced Season-Long Grub control Biunik-200SL CP-1 CP1 Comodor Confidate Confidor-100SL 240 200-O-TEQ OTEQ 200SL 70WG SL CoreTect Couraze-Max Enforce Gaucho-600FS Grande Genesis Grubex Hachikusan Imicide Jade Kohinor Kumiai Lada Macho Max Mallet Marathon-II Merit Meritgreen NTN-33893 33893240FS NUP-06023 06024 NUQ-05054 NUP06023 NUP06024 NUQ05054 Nuprid Pasada Premis Premise Prescribe Preventol-TM Pro-Agro Provado Quick-Bayt Rinfidor Senator Tanrec Timbertreat-N-98 N98 Torrent Trimax-Pro Widow Yashijing Myzus Drosophila
- Product Overview:
Imidacloprid is a broad-spectrum neonicotinoid insecticide that is effective against sucking and biting insects and insects of the Coleopteran and Lepidoptera orders.{42081,42083} It is an agonist of insect acetylcholine receptors (nAchRs) with Ki values of 1.9, 2.1, 290, and 50 nM for M. persicae and D. melanogaster receptors, rat brain membranes, and rat recombinant receptors containing ?4?2 subunits, respectively.{42082,33400} Imidacloprid is lethal to M. persicae with LD95 values of approximately 2 and 160 pg/aphid via oral and topical administration, respectively.{42083} It impairs aversive learning and memory retention in honey bees following chronic sublethal exposure of 20.8 ppb.{42084} In a mouse model of high-fat diet-induced obesity, imidacloprid (0.06-6 mg/kg per day) increases body weight gain and adiposity and impairs glucose metabolism without increasing total food intake.{42085}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.